Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc R Radke

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal for Parasitology. Parasites and Wildlife|December 21, 2018
Molecular phylogenetics and species-level systematics of <i>Baylisascaris</i>Lauren E Camp, Marc R Radke, Danny M Shihabi, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Dynamic Monitoring of Recurrent Ovarian Cancer Using Serial ctDNA: A Real-World Case SeriesEric Rios-Doria, Jonathan B Reichel, Marc R Radke, et al.
Cold Spring Harbor Molecular Case Studies|April 9, 2021
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutationMeghan R Sullivan, Rohit Prakash, Yashpal Rawal, et al.
Cancer Research|December 12, 2019
Rare <i>BRIP1</i> Missense Alleles Confer Risk for Ovarian and Breast CancerCassandra L Moyer, Jennifer Ivanovich, Jessica L Gillespie, et al.
Gynecologic Oncology|December 30, 2020
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutationsTalayeh S Ghezelayagh, Kathryn P Pennington, Barbara M Norquist, et al.
Science Translational Medicine|July 20, 2022
Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomasFrancesca Menghi, Kalyan Banda, Pooja Kumar, et al.
Oncogene|June 25, 2024
TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutationsTalayeh S Ghezelayagh, Brendan F Kohrn, Jeanne Fredrickson, et al.
Nature Communications|December 13, 2019
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistanceYifan Wang, Andrea J Bernhardy, Joseph Nacson, et al.
Gynecologic Oncology|December 17, 2019
Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinomaJeffrey D Krimmel-Morrison, Talayeh S Ghezelayagh, Shenyi Lian, et al.
Gynecologic Oncology|August 11, 2024
Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutationsXin Ray Tee, Emma Hazard, Elena Latorre-Esteves, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal for Parasitology. Parasites and Wildlife|December 21, 2018
Molecular phylogenetics and species-level systematics of <i>Baylisascaris</i>Lauren E Camp, Marc R Radke, Danny M Shihabi, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Dynamic Monitoring of Recurrent Ovarian Cancer Using Serial ctDNA: A Real-World Case SeriesEric Rios-Doria, Jonathan B Reichel, Marc R Radke, et al.
Cold Spring Harbor Molecular Case Studies|April 9, 2021
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutationMeghan R Sullivan, Rohit Prakash, Yashpal Rawal, et al.
Cancer Research|December 12, 2019
Rare <i>BRIP1</i> Missense Alleles Confer Risk for Ovarian and Breast CancerCassandra L Moyer, Jennifer Ivanovich, Jessica L Gillespie, et al.
Gynecologic Oncology|December 30, 2020
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutationsTalayeh S Ghezelayagh, Kathryn P Pennington, Barbara M Norquist, et al.
Science Translational Medicine|July 20, 2022
Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomasFrancesca Menghi, Kalyan Banda, Pooja Kumar, et al.
Oncogene|June 25, 2024
TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutationsTalayeh S Ghezelayagh, Brendan F Kohrn, Jeanne Fredrickson, et al.
Nature Communications|December 13, 2019
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistanceYifan Wang, Andrea J Bernhardy, Joseph Nacson, et al.
Gynecologic Oncology|December 17, 2019
Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinomaJeffrey D Krimmel-Morrison, Talayeh S Ghezelayagh, Shenyi Lian, et al.
Gynecologic Oncology|August 11, 2024
Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutationsXin Ray Tee, Emma Hazard, Elena Latorre-Esteves, et al.
Pageof 3